Connection
Marc Bonaca to Serotonin 5-HT2 Receptor Agonists
This is a "connection" page, showing publications Marc Bonaca has written about Serotonin 5-HT2 Receptor Agonists.
|
|
Connection Strength |
|
 |
|
 |
|
0.163 |
|
|
|
-
Scirica BM, Bohula EA, Dwyer JP, Qamar A, Inzucchi SE, McGuire DK, Keech AC, Smith SR, Murphy SA, Im K, Leiter LA, Gupta M, Patel T, Miao W, Perdomo C, Bonaca MP, Ruff CT, Sabatine MS, Wiviott SD. Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial. Circulation. 2019 01 15; 139(3):366-375.
Score: 0.163